Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 311/29 (2006.01) C07C 311/39 (2006.01) C07C 311/47 (2006.01) C07C 311/64 (2006.01) C07D 207/12 (2006.01) C07D 207/16 (2006.01) C07D 207/27 (2006.01) C07D 209/20 (2006.01) C07D 211/66 (2006.01) C07D 213/32 (2006.01) C07D 213/42 (2006.01) C07D 213/70 (2006.01) C07D 213/71 (2006.01) C07D 213/81 (2006.01) C07D 213/82 (2006.01) C07D 215/48 (2006.01) C07D 217/26 (2006.01) C07D 235/06 (2006.01) C07D 241/04 (2006.01) C07D 243/08 (2006.01) C07D 261/18 (2006.01) C07D 265/30 (2006.01) C07D 277/06 (2006.01) C07D 2

Patent

CA 2356299

Compound of the formula (B) are useful in treating disease conditions mediated by TNF-.alpha., such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.

Cette invention concerne des composés correspondant à la formule (B) qui sont utiles dans le traitement d'états maladifs induits par le facteur de nécrose tumorale .alpha., tels que l'arthrite rhumatoïde, l'arthrose, la septicémie, le SIDA, la colite ulcéreuse, la sclérose multiple, la maladie de Crohn et la perte de cartilage dégénérative.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1695832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.